Using artificial intelligence to give pharma and biotech a leg up
Unique AI method developed at Chalmers for generating proteins could speed up drug development
Preclinical Research
Two novel chronic kidney disease candidates arise
CKD is a slow and progressive loss of kidney function over several years, which can eventually cause permanent kidney failure. CKD often goes undetected and undiagnosed until the disease is well advanced, and the damage is irreversible resulting in poor survival rates. There are estimated to be 700 million cases of CKD worldwide, and currently there is no cure.
Lifelike systems
Organ-on-chip and tissue-on-chip models continue to advance drug discovery
A double-barrel approach
Peptide drug targets two cancer proteins for increased specificity and uptake
Alternating two-vector therapies prove promising
Data on HOOKIPA’s cancer therapeutics have been published in Cell Reports Medicine
New study maps wildlife microbiota for human benefit
Wild Biotech says it is discovering millions of previously unknown potential human therapeutics
Deep brain stimulation for Parkinson's disease
New discoveries suggest it is on par with therapeutics and speeds the process of recovery and adoption of personalized treatment
Connecting biology with machine learning
Broad Institute launches the Eric and Wendy Schmidt Center for better understanding programs of life
Bringing siRNA across the barrier
Bioasis announces publication evaluating CNS delivery of siRNA via the company’s xB³ platform
Focus Feature on Neuroscience: Preclinical progress on neurodegeneration
Making the rounds of brain-related therapeutic and diagnostic R&D, with a focus on neurodegenerative disease and dementia
Real world evidence market is growing fast
Applications of RWE-based insights range from drug discovery to supporting regulatory decision-making
